SEC Form 4 · accession 0001209191-15-040809
HYPERION THERAPEUTICS INC · HPTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ashley C. Gould
Officer — SVP Govt Aff & Chief Legal Ofc
Period of report
May 7, 2015
Accepted (ET)
May 8, 2015 · 7:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386858
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 7, 2015 | U | 801 | $46.00 | D | 0 | D | |
| Common StockF2 | May 7, 2015 | D | 21,775 | $46.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $26.50 | May 7, 2015 | D | 84,000 | D | — | Jul 18, 2023 | Common Stock | 84,000 | 0 | D |
| Stock Option (Right to Buy)F3 | $26.74 | May 7, 2015 | D | 34,000 | D | — | Mar 10, 2024 | Common Stock | 34,000 | 0 | D |
| Stock Option (Right to Buy)F3 | $25.97 | May 7, 2015 | D | 26,500 | D | — | Feb 8, 2025 | Common Stock | 26,500 | 0 | D |
Explanation of responses
- F1Shares that were tendered pursuant to the offer from Horizon Pharma plc ("Horizon") to acquire shares of the issuer.
- F2Restricted stock units covering shares of issuer common stock that will be cashed-out and cancelled in connection with the merger of the issuer and Horizon (the "Merger").
- F3Options to acquire shares of issuer common stock that will be cashed-out and cancelled in connection with the Merger.